Jobs / United States / Regeneron Pharmaceuticals INC
Director, Medical Affairs - Rare Diseases
Regeneron Pharmaceuticals INC · 🇺🇸 Amsterdam3
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Regeneron Pharmaceuticals INC paid sponsored hires in similar roles4 certified filings for “Exec Medical Director Clinical Sciences” (Medical and Health Services Managers) in NY: $380k–$450k, median $415k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Regeneron Pharmaceuticals INC
The US Department of Labor certified 290 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 40 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Regeneron Pharmaceuticals INC →
About the role
Build our future together: At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Director, Medical Affairs, Rare Diseases - Europe to join our Medical Affairs team. In this hybrid role, you will lead medical strategy and scientific engagement across investigational and approved therapies in rare diseases. Working closely with Global Medical Affairs, Clinical Development, HEOR, Medical Operations, Publications and Statistics, you will drive evidence generation, build scientific partnerships and translate external insights into strategic recommendations supporting patient needs and medical excellence. When & where: Amsterdam (Hybrid) Discover your role: • Lead medical strategies and tactical plans across assigned rare disease assets and therapeutic areas. • Provide scientific and medical leadership throughout pre-launch, launch and post-launch phases. • Establish scientific partnerships with healthcare professionals, researchers, advocacy organisations, payers and other external stakeholders. • Drive evidence generation through Medical Affairs studies, data analysis, publications and scientific communication plans. • Translate clinical and country insights into recommendations supporting medical strategy, patient access and value demonstration. • Manage complex priorities, budgets and timelines while maintaining scientific integrity and compliance. • You bring a collaborative, patient-focused approach to scientific leadership and external engagement. This role requires: • MD, DO, PharmD, PhD or an equivalent advanced scientific or clinical degree. • Minimum 8 years of Medical Affairs experience with increasing responsibility. • Expertise in rare diseases and/or genetic medicine. • Experience leading medical strategy, scientific communications and evidence generation. • Strong understanding of drug development and lifecycle management. • Fluency in English and willingness to travel nationally and internationally approximately 30–50%. • Experience in rare genetic diseases, gene therapy, regenerative medicine or rare bone, muscle or cardiovascular disorders preferred. • Product launch, clinical trial, publication or field Medical Affairs leadership experience preferred. • Multi-country experience and additional languages preferred. Does this sound like you? Apply now to take your first step towards living the Regeneron Way! We are committed to building a workplace with an inclusive culture. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law. Where required, we will provide reasonable accommodation to applicants with known disabilities or chronic illnesses during the recruitment process, unless such accommodation would impose undue hardship. Where necessary, we disclose salary ranges for roles in all countries in which we operate. The final offer will be determined within the relevant range based on the country of employment, specific role level, and your skills and experience. In some countries, collective bargaining agreements (CBAs) may apply and influence certain elements of pay or benefits. Regeneron offers a competitive and comprehensive total rewards package which may include, depending on country and role: ann